T8	B-Entity	0	1	N	N	B-NP	NN	O	7	NMOD	O
T8	I-Entity	1	2	-	-	I-NP	HYPH	O	7	NMOD	O
T8	I-Entity	2	8	acetyl	acetyl	I-NP	NN	O	7	NMOD	O
T8	I-Entity	8	9	-	-	B-NP	HYPH	O	7	NMOD	O
T8	I-Entity	9	10	L	L	I-NP	NN	O	7	NMOD	O
T8	I-Entity	10	11	-	-	O	HYPH	O	7	NMOD	O
T8	I-Entity	11	19	cysteine	cysteine	B-NP	NN	O	8	SUB	O
O	O	20	28	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	29	36	primary	primary	B-NP	JJ	O	13	NMOD	O
O	O	37	42	human	human	I-NP	JJ	O	13	NMOD	O
O	O	43	44	T	T	I-NP	NN	O	13	NMOD	O
O	O	45	49	cell	cell	I-NP	NN	O	13	NMOD	O
O	O	50	59	responses	response	I-NP	NNS	O	8	OBJ	O
O	O	60	62	at	at	B-PP	IN	O	8	VMOD	O
O	O	63	66	the	the	B-NP	DT	O	18	NMOD	O
O	O	67	76	dendritic	dendritic	I-NP	JJ	O	18	NMOD	O
O	O	77	81	cell	cell	I-NP	NN	O	18	NMOD	O
O	O	82	87	level	level	I-NP	NN	O	14	PMOD	O
O	O	87	88	:	:	O	:	O	8	P	O
O	O	89	100	association	association	B-NP	NN	O	8	VMOD	O
O	O	101	105	with	with	B-PP	IN	O	20	NMOD	O
T9	B-Entity	106	108	NF	NF	B-NP	NN	B-protein	24	NMOD	B-protein
T9	I-Entity	108	109	-	-	I-NP	HYPH	I-protein	24	NMOD	I-protein
T9	I-Entity	109	115	kappaB	kappaB	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	116	126	inhibition	inhibition	I-NP	NN	O	21	PMOD	O
O	O	126	127	.	.	O	.	O	8	P	O

T10	B-Entity	129	130	N	N	B-NP	NN	O	11	SUB	O
T10	I-Entity	130	131	-	-	I-NP	HYPH	O	11	VMOD	O
T10	I-Entity	131	137	acetyl	acetyl	I-NP	NN	O	11	VMOD	O
T10	I-Entity	137	138	-	-	B-NP	HYPH	O	11	P	O
T10	I-Entity	138	139	L	L	I-NP	NN	O	11	VMOD	O
T10	I-Entity	139	140	-	-	O	HYPH	O	11	P	O
T10	I-Entity	140	148	cysteine	cysteine	B-NP	NN	O	11	SUB	O
O	O	149	150	(	(	O	(	O	10	DEP	O
T11	B-Entity	150	153	NAC	NAC	B-NP	NN	O	10	DEP	O
O	O	153	154	)	)	O	)	O	7	NMOD	O
O	O	155	157	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	158	160	an	an	B-NP	DT	O	14	NMOD	O
O	O	161	172	antioxidant	antioxidant	I-NP	JJ	O	14	NMOD	O
O	O	173	181	molecule	molecule	I-NP	NN	O	11	PRD	O
O	O	182	189	endowed	endow	B-VP	VBN	O	14	NMOD	O
O	O	190	194	with	with	B-PP	IN	O	15	VMOD	O
O	O	195	211	immunomodulatory	immunomodulatory	B-NP	JJ	O	18	NMOD	O
O	O	212	222	properties	property	I-NP	NNS	O	16	PMOD	O
O	O	222	223	.	.	O	.	O	11	P	O

O	O	224	226	To	To	B-VP	TO	O	2	VMOD	O
O	O	227	238	investigate	investigate	I-VP	VB	O	17	VMOD	O
O	O	239	242	the	the	B-NP	DT	O	4	NMOD	O
O	O	243	249	effect	effect	I-NP	NN	O	2	OBJ	O
O	O	250	252	of	of	B-PP	IN	O	4	NMOD	O
T12	B-Entity	253	256	NAC	NAC	B-NP	NN	O	5	PMOD	O
O	O	257	259	on	on	B-PP	IN	O	4	NMOD	O
O	O	260	263	the	the	B-NP	DT	O	10	NMOD	O
O	O	264	273	induction	induction	I-NP	NN	O	10	NMOD	O
O	O	274	279	phase	phase	I-NP	NN	O	7	PMOD	O
O	O	280	282	of	of	B-PP	IN	O	10	NMOD	O
O	O	283	284	T	T	B-NP	NN	O	14	NMOD	O
O	O	285	289	cell	cell	I-NP	NN	O	14	NMOD	O
O	O	290	299	responses	response	I-NP	NNS	O	11	PMOD	O
O	O	299	300	,	,	O	,	O	17	P	O
O	O	301	303	we	we	B-NP	PRP	O	17	SUB	O
O	O	304	312	analyzed	analyze	B-VP	VBD	O	0	ROOT	O
O	O	313	316	its	its	B-NP	PRP$	O	19	NMOD	O
O	O	317	323	action	action	I-NP	NN	O	17	OBJ	O
O	O	324	326	on	on	B-PP	IN	O	19	NMOD	O
O	O	327	332	human	human	B-NP	JJ	B-cell_type	23	NMOD	B-cell_type
O	O	333	342	dendritic	dendritic	I-NP	JJ	I-cell_type	23	NMOD	I-cell_type
O	O	343	348	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	349	350	(	(	O	(	O	26	DEP	O
O	O	350	352	DC	DC	B-NP	NN	B-cell_type	26	DEP	B-cell_type
O	O	352	353	)	)	O	)	O	23	NMOD	O
O	O	354	361	derived	derive	B-VP	VBN	O	23	NMOD	O
O	O	362	366	from	from	B-PP	IN	O	27	VMOD	O
O	O	367	375	adherent	adherent	B-NP	JJ	O	30	NMOD	O
O	O	376	380	PBMC	PBMC	I-NP	NN	B-cell_type	28	PMOD	B-cell_type
O	O	381	389	cultured	culture	B-VP	VBN	O	30	NMOD	O
O	O	390	394	with	with	B-PP	IN	O	31	VMOD	O
T1	B-Protein	395	397	IL	IL	B-NP	NN	B-protein	40	NMOD	B-protein
T1	I-Protein	397	398	-	-	B-NP	HYPH	I-protein	33	NMOD	I-protein
T1	I-Protein	398	399	4	4	I-NP	CD	I-protein	34	NMOD	I-protein
O	O	400	403	and	and	I-NP	CC	O	40	NMOD	O
T2	B-Protein	404	415	granulocyte	granulocyte	I-NP	NN	B-protein	40	NMOD	B-protein
T2	I-Protein	415	416	-	-	I-NP	HYPH	I-protein	40	NMOD	I-protein
T2	I-Protein	416	426	macrophage	macrophage	I-NP	NN	I-protein	40	NMOD	I-protein
T2	I-Protein	427	430	CSF	CSF	I-NP	NN	I-protein	32	PMOD	I-protein
O	O	430	431	.	.	O	.	O	17	P	O

O	O	432	434	We	We	B-NP	PRP	O	3	SUB	O
O	O	435	440	first	first	B-ADVP	RB	O	3	VMOD	O
O	O	441	446	found	find	B-VP	VBD	O	0	ROOT	O
O	O	447	451	that	that	B-SBAR	IN	O	3	VMOD	O
T13	B-Entity	452	455	NAC	NAC	B-NP	NN	O	6	SUB	O
O	O	456	465	inhibited	inhibit	B-VP	VBD	O	4	SBAR	O
O	O	466	469	the	the	B-NP	DT	O	8	NMOD	O
O	O	470	482	constitutive	constitutive	I-NP	JJ	O	6	OBJ	O
O	O	483	485	as	as	B-CONJP	RB	O	13	NMOD	O
O	O	486	490	well	well	I-CONJP	RB	O	9	DEP	O
O	O	491	493	as	as	I-CONJP	IN	O	9	DEP	O
O	O	494	497	the	the	B-NP	DT	O	13	NMOD	O
O	O	498	501	LPS	LPS	I-NP	NN	O	8	NMOD	O
O	O	501	502	-	-	B-VP	HYPH	O	13	NMOD	O
O	O	502	509	induced	induce	B-NP	VBN	O	16	NMOD	O
O	O	510	518	activity	activity	I-NP	NN	O	14	OBJ	O
O	O	519	521	of	of	B-PP	IN	O	16	NMOD	O
O	O	522	525	the	the	B-NP	DT	O	20	NMOD	O
T14	B-Entity	526	539	transcription	transcription	I-NP	NN	B-protein	20	NMOD	B-protein
T14	I-Entity	540	546	factor	factor	I-NP	NN	I-protein	23	NMOD	I-protein
T14	I-Entity	547	549	NF	NF	I-NP	NN	B-protein	23	NMOD	B-protein
T14	I-Entity	549	550	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T14	I-Entity	550	556	kappaB	kappaB	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	556	557	.	.	O	.	O	3	P	O

O	O	558	560	In	In	B-PP	IN	O	5	VMOD	O
O	O	561	569	parallel	parallel	B-NP	NN	O	1	PMOD	O
O	O	569	570	,	,	O	,	O	5	P	O
T15	B-Entity	571	574	NAC	NAC	B-NP	NN	O	5	SUB	O
O	O	575	578	was	be	B-VP	VBD	O	0	ROOT	O
O	O	579	584	shown	show	I-VP	VBN	O	5	VC	O
O	O	585	587	to	to	I-VP	TO	O	6	VMOD	O
O	O	588	592	down	down	I-VP	RB	O	9	VMOD	O
O	O	592	593	-	-	I-VP	HYPH	O	7	PMOD	O
O	O	593	601	regulate	regulate	I-VP	VB	O	9	VC	O
O	O	602	605	the	the	B-NP	DT	O	12	NMOD	O
O	O	606	616	production	production	I-NP	NN	O	10	OBJ	O
O	O	617	619	of	of	B-PP	IN	O	12	NMOD	O
O	O	620	629	cytokines	cytokine	B-NP	NNS	B-protein	13	PMOD	B-protein
O	O	630	632	by	by	B-PP	IN	O	12	NMOD	O
O	O	633	635	DC	DC	B-NP	NN	B-cell_type	15	PMOD	B-cell_type
O	O	636	638	as	as	B-CONJP	RB	O	19	PMOD	O
O	O	639	643	well	well	I-CONJP	RB	O	19	PMOD	O
O	O	644	646	as	as	I-CONJP	IN	O	10	VMOD	O
O	O	647	652	their	their	B-NP	PRP$	O	22	NMOD	O
O	O	653	660	surface	surface	I-NP	NN	O	22	NMOD	O
O	O	661	671	expression	expression	I-NP	NN	O	19	PMOD	O
O	O	672	674	of	of	B-PP	IN	O	22	NMOD	O
O	O	675	678	HLA	HLA	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	678	679	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
O	O	679	681	DR	DR	I-NP	NN	I-protein	37	NMOD	I-protein
O	O	681	682	,	,	O	,	O	37	P	O
T3	B-Protein	683	687	CD86	CD86	B-NP	NN	B-protein	37	NMOD	B-protein
O	O	688	689	(	(	O	(	O	33	DEP	O
T4	B-Protein	689	691	B7	B7	B-NP	NN	B-protein	32	NMOD	B-protein
T4	I-Protein	691	692	-	-	O	HYPH	O	32	P	O
T4	I-Protein	692	693	2	2	B-NP	CD	O	33	DEP	O
O	O	693	694	)	)	O	)	O	28	NMOD	O
O	O	694	695	,	,	O	,	O	37	P	O
O	O	696	699	and	and	O	CC	O	37	NMOD	O
T5	B-Protein	700	704	CD40	CD40	B-NP	NN	B-protein	37	NMOD	B-protein
O	O	705	714	molecules	molecule	I-NP	NNS	I-protein	23	PMOD	I-protein
O	O	715	719	both	both	B-PP	CC	O	23	PMOD	O
O	O	720	722	at	at	B-PP	IN	O	23	PMOD	O
O	O	723	726	the	the	B-NP	DT	O	42	NMOD	O
O	O	727	732	basal	basal	I-NP	JJ	O	42	NMOD	O
O	O	733	738	state	state	I-NP	NN	O	39	PMOD	O
O	O	739	742	and	and	B-PP	CC	O	39	PMOD	O
O	O	743	747	upon	upon	B-PP	IN	O	39	PMOD	O
O	O	748	751	LPS	LPS	B-NP	NN	O	46	NMOD	O
O	O	752	762	activation	activation	I-NP	NN	O	44	PMOD	O
O	O	762	763	.	.	O	.	O	5	P	O

T16	B-Entity	764	767	NAC	NAC	B-NP	NN	O	3	SUB	O
O	O	768	772	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	773	782	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	783	785	DC	DC	B-NP	NN	B-cell_type	5	NMOD	B-cell_type
O	O	786	795	responses	response	I-NP	NNS	O	3	OBJ	O
O	O	796	803	induced	induce	B-VP	VBN	O	5	NMOD	O
O	O	804	806	by	by	B-PP	IN	O	6	VMOD	O
T6	B-Protein	807	811	CD40	CD40	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	812	822	engagement	engagement	I-NP	NN	O	7	PMOD	O
O	O	822	823	.	.	O	.	O	3	P	O

O	O	824	827	The	The	B-NP	DT	O	3	NMOD	O
O	O	828	838	inhibitory	inhibitory	I-NP	JJ	O	3	NMOD	O
O	O	839	846	effects	effect	I-NP	NNS	O	6	SUB	O
O	O	847	849	of	of	B-PP	IN	O	3	NMOD	O
T17	B-Entity	850	853	NAC	NAC	B-NP	NN	O	4	PMOD	O
O	O	854	858	were	be	B-VP	VBD	O	0	ROOT	O
O	O	859	862	not	not	O	RB	O	6	VMOD	O
O	O	863	866	due	due	B-ADJP	JJ	O	9	PMOD	O
O	O	867	869	to	to	B-PP	TO	O	6	PRD	O
O	O	870	881	nonspecific	nonspecific	B-NP	JJ	O	11	NMOD	O
O	O	882	890	toxicity	toxicity	I-NP	NN	O	9	PMOD	O
O	O	891	893	as	as	B-PP	IN	O	6	VMOD	O
O	O	894	901	neither	neither	O	CC	O	24	NMOD	O
O	O	902	905	the	the	B-NP	DT	O	15	NMOD	O
O	O	906	915	viability	viability	I-NP	NN	O	21	NMOD	O
O	O	916	918	of	of	B-PP	IN	O	15	NMOD	O
O	O	919	921	DC	DC	B-NP	NN	B-cell_type	16	PMOD	B-cell_type
O	O	922	925	nor	nor	O	CC	O	21	NMOD	O
O	O	926	931	their	their	B-NP	PRP$	O	21	NMOD	O
T7	B-Protein	932	939	mannose	mannose	I-NP	NN	B-protein	21	NMOD	B-protein
T7	I-Protein	940	948	receptor	receptor	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	948	949	-	-	B-VP	HYPH	O	24	NMOD	O
O	O	949	957	mediated	mediate	B-NP	VBN	O	24	NMOD	O
O	O	958	969	endocytosis	endocytosis	I-NP	NN	O	25	SUB	O
O	O	970	974	were	be	B-VP	VBD	O	12	SBAR	O
O	O	975	983	modified	modify	I-VP	VBN	O	25	VC	O
O	O	984	986	by	by	B-PP	IN	O	26	VMOD	O
T18	B-Entity	987	990	NAC	NAC	B-NP	NN	O	27	PMOD	O
O	O	990	991	.	.	O	.	O	6	P	O

O	O	992	999	Finally	Finally	B-ADVP	RB	O	4	VMOD	O
O	O	999	1000	,	,	O	,	O	4	P	O
O	O	1001	1003	we	we	B-NP	PRP	O	4	SUB	O
O	O	1004	1009	found	find	B-VP	VBD	O	0	ROOT	O
O	O	1010	1014	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	1015	1018	the	the	B-NP	DT	O	7	NMOD	O
O	O	1019	1027	addition	addition	I-NP	NN	O	19	SUB	O
O	O	1028	1030	of	of	B-PP	IN	O	7	NMOD	O
T19	B-Entity	1031	1034	NAC	NAC	B-NP	NN	O	8	PMOD	O
O	O	1035	1037	to	to	B-PP	TO	O	7	NMOD	O
O	O	1038	1041	MLR	MLR	B-NP	NN	B-protein	10	PMOD	B-protein
O	O	1042	1049	between	between	B-PP	IN	O	11	NMOD	O
O	O	1050	1055	naive	naive	B-NP	JJ	B-cell_type	15	NMOD	B-cell_type
O	O	1056	1057	T	T	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	1058	1063	cells	cell	I-NP	NNS	I-cell_type	18	NMOD	I-cell_type
O	O	1064	1067	and	and	O	CC	O	18	NMOD	O
O	O	1068	1078	allogeneic	allogeneic	B-NP	JJ	O	18	NMOD	O
O	O	1079	1081	DC	DC	I-NP	NN	B-cell_type	12	PMOD	B-cell_type
O	O	1082	1090	resulted	result	B-VP	VBD	O	5	SBAR	O
O	O	1091	1093	in	in	B-PP	IN	O	19	VMOD	O
O	O	1094	1095	a	a	B-NP	DT	O	23	NMOD	O
O	O	1096	1104	profound	profound	I-NP	JJ	O	23	NMOD	O
O	O	1105	1115	inhibition	inhibition	I-NP	NN	O	44	SUB	O
O	O	1116	1118	of	of	B-PP	IN	O	23	NMOD	O
O	O	1119	1131	alloreactive	alloreactive	B-NP	JJ	O	26	NMOD	O
O	O	1132	1141	responses	response	I-NP	NNS	O	24	PMOD	O
O	O	1141	1142	,	,	O	,	O	23	P	O
O	O	1143	1148	which	which	B-NP	WDT	O	23	NMOD	O
O	O	1149	1154	could	could	B-VP	MD	O	28	SBAR	O
O	O	1155	1157	be	be	I-VP	VB	O	29	VC	O
O	O	1158	1168	attributed	attribute	I-VP	VBN	O	30	VC	O
O	O	1169	1171	to	to	B-PP	TO	O	31	VMOD	O
O	O	1172	1173	a	a	B-NP	DT	O	34	NMOD	O
O	O	1174	1180	defect	defect	I-NP	NN	O	32	PMOD	O
O	O	1181	1183	of	of	B-PP	IN	O	34	NMOD	O
O	O	1184	1186	DC	DC	B-NP	NN	B-cell_type	35	PMOD	B-cell_type
O	O	1187	1189	as	as	B-PP	IN	O	34	NMOD	O
O	O	1190	1193	APC	APC	B-NP	NN	B-cell_type	43	NMOD	B-cell_type
O	O	1193	1194	-	-	B-NP	HYPH	O	43	NMOD	O
O	O	1194	1205	independent	independent	I-NP	JJ	O	43	NMOD	O
O	O	1206	1207	T	T	I-NP	NN	O	43	NMOD	O
O	O	1208	1212	cell	cell	I-NP	NN	O	43	NMOD	O
O	O	1213	1222	responses	response	I-NP	NNS	O	37	PMOD	O
O	O	1223	1227	were	be	B-VP	VBD	O	20	SBAR	O
O	O	1228	1231	not	not	I-VP	RB	O	44	VMOD	O
O	O	1232	1241	inhibited	inhibit	I-VP	VBN	O	44	VC	O
O	O	1242	1244	by	by	B-PP	IN	O	46	VMOD	O
T20	B-Entity	1245	1248	NAC	NAC	B-NP	NN	O	47	PMOD	O
O	O	1248	1249	.	.	O	.	O	4	P	O

O	O	1250	1260	Altogether	Altogether	B-ADVP	RB	O	5	VMOD	O
O	O	1260	1261	,	,	O	,	O	5	P	O
O	O	1262	1265	our	our	B-NP	PRP$	O	4	NMOD	O
O	O	1266	1273	results	result	I-NP	NNS	O	5	SUB	O
O	O	1274	1281	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1282	1286	that	that	B-SBAR	IN	O	5	VMOD	O
T21	B-Entity	1287	1290	NAC	NAC	B-NP	NN	O	8	SUB	O
O	O	1291	1296	might	might	B-VP	MD	O	6	SBAR	O
O	O	1297	1303	impair	impair	I-VP	VB	O	8	VC	O
O	O	1304	1307	the	the	B-NP	DT	O	11	NMOD	O
O	O	1308	1318	generation	generation	I-NP	NN	O	9	OBJ	O
O	O	1319	1321	of	of	B-PP	IN	O	11	NMOD	O
O	O	1322	1329	primary	primary	B-NP	JJ	O	15	NMOD	O
O	O	1330	1336	immune	immune	I-NP	JJ	O	15	NMOD	O
O	O	1337	1346	responses	response	I-NP	NNS	O	12	PMOD	O
O	O	1347	1349	in	in	B-PP	IN	O	11	NMOD	O
O	O	1350	1356	humans	human	B-NP	NNS	O	16	PMOD	O
O	O	1357	1364	through	through	B-PP	IN	O	9	VMOD	O
O	O	1365	1368	its	its	B-NP	PRP$	O	21	NMOD	O
O	O	1369	1379	inhibitory	inhibitory	I-NP	JJ	O	21	NMOD	O
O	O	1380	1386	action	action	I-NP	NN	O	18	PMOD	O
O	O	1387	1389	on	on	B-PP	IN	O	21	NMOD	O
O	O	1390	1392	DC	DC	B-NP	NN	B-cell_type	22	PMOD	B-cell_type
O	O	1392	1393	.	.	O	.	O	5	P	O
